Andfjord Salmon: Healthy biological performance and growth | Returning to revenue generation | Q2/H1 2026 financial results27.8.2026 07:00:08 CEST | Andfjord Salmon | Half year financial report
Andfjord Salmon Group AS ("Andfjord Salmon" or "the company") is pleased to announce continued strong biological performance, with an aggregate survival rate of 98.04% and 57% biomass growth in less than two months, maintained through the second quarter and into the third quarter. Further, the company returned to revenue generation in the second quarter following its first post-smolt sale in June.
